Current issue
Archive
About the Journal
About us
Aims and Scope
Indexing and Abstracting
Editorial Office
Open Access Policy
Publication Ethics
Contact
For Authors
Editorial Policy
Peer Review Policy
Manuscript Preparation Guidelines
Copyright & Licensing
Publication Fees
Fast-Track Paper Publication Option
Conflict Interest Guidance
Submit an Article
Special Issues
News & Editorials
“Fake,” “Predatory,” and “Pseudo” Journals: Charlatans Threatening Trust in Science
Shifting the Journal submission-review system to the Editorial System Manuscript December 27, 2017.
ORIGINAL ARTICLE
Common genetic abnormalities and phenotypic scoring in Saudi patients with acute B-lymphoblastic leukemia
1
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam, SAUDI ARABIA
2
Deanship of Scientific Research, Imam Abdulrahman Bin Faisal University, Dammam, SAUDI ARABIA
3
Department of Hematology and Immunohematology, College of Medical Laboratory Science, Sudan University of Science and Technology, Khartoum, SUDAN
Online publication date: 2023-08-06
Publication date: 2023-11-01
Electron J Gen Med 2023;20(6):em536
KEYWORDS
ABSTRACT
Introduction:
B-acute lymphoblastic leukemia (B-ALL) is a malignant neoplasm of hematopoietic stem cells originating in bone marrow and characterized by proliferation of blast cells of lymphoid series. The aim of this study was to predictive scoring system (SS) using a fully standardized EuroFlow eight-color panel.
Methods:
The expression of the different cluster of differentiation (CD) markers involved in the B-ALL EuroFlow panel was investigated by measuring their positivity, percentage, and median fluorescence intensity.
Results:
CD9, CD123, and TdT were used to predict TCF3PBX1 with 80.0% sensitivity (SN) and 100% specificity (SP). CD20 and CD66 were used to predict hypoploidy with 63.0% SN and 100% SP. As a result, no useful discriminative SS was developed.
Conclusions:
Four SSs were proposed for the prediction of the most common cytogenetic abnormalities of Saudi B-ALL.
B-acute lymphoblastic leukemia (B-ALL) is a malignant neoplasm of hematopoietic stem cells originating in bone marrow and characterized by proliferation of blast cells of lymphoid series. The aim of this study was to predictive scoring system (SS) using a fully standardized EuroFlow eight-color panel.
Methods:
The expression of the different cluster of differentiation (CD) markers involved in the B-ALL EuroFlow panel was investigated by measuring their positivity, percentage, and median fluorescence intensity.
Results:
CD9, CD123, and TdT were used to predict TCF3PBX1 with 80.0% sensitivity (SN) and 100% specificity (SP). CD20 and CD66 were used to predict hypoploidy with 63.0% SN and 100% SP. As a result, no useful discriminative SS was developed.
Conclusions:
Four SSs were proposed for the prediction of the most common cytogenetic abnormalities of Saudi B-ALL.
REFERENCES (17)
1.
Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194(11):1625-38. https://doi.org/10.1084/jem.19... PMid:11733577 PMCid:PMC2193527.
2.
Mullighan CG. Molecular genetics of B-precursor acute lymphoblastic leukemia. J Clin Invest. 2012;122(10):3407-15. https://doi.org/10.1172/JCI612... PMid:23023711 PMCid:PMC3461902.
3.
Hakeem A, Shiekh AA, Bhat GM, Lone AR. Prognostification of ALL by cytogenetics. Indian J of Hematol Blood Transfus. 2014;31(3):322-31. https://doi.org/10.1007/s12288... PMid:26085716 PMCid:PMC4465518.
4.
Owaidah TM, Rawas FI, Al Khayatt MF, Elkum NB. Expression of CD66c and CD25 in acute lymphoblastic leukemia as a predictor of the presence of BCR/ABL rearrangement. Hematol Oncol Stem Cell Ther. 2008;1(1):34-7. https://doi.org/10.1016/S1658-... PMid:20063526.
5.
Loghavi S, Kutok JL, Jorgensen JL. B-acute lymphoblastic leukemia/lymphoblastic lymphoma. Am J Clin Pathol. 2015;144(3):393-410. https://doi.org/10.1309/AJCPAN... PMid:26276770.
6.
Primo D, Tabernero MD, Perez JJ, et al. Genetic heterogeneity of BCR/ABL+ adult B-cell precursor acute lymphoblastic leukemia: Impact on the clinical, biological and immunophenotypical disease characteristics. Leukemia. 2005;19(5):713-20. https://doi.org/10.1038/sj.leu... PMid:15789066.
7.
He G-Q, Guo X, Jiang M-Y, et al. Co-occurrence of TCF3-PBX1 gene fusion, and chromosomal aberration in a pediatric pre-B cell acute lymphoblastic leukemia with clitoris swelling. Medicine (Baltimore). 2021;100(8):e24802. https://doi.org/10.1097/MD.000... PMid:33663097 PMCid:PMC7909158.
8.
Djokic M, Bjorklund E, Blennow E, Mazur J, Soderhall S, Porwit A. Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia. Haematologica. 2009;94(7):1016-9. https://doi.org/10.3324/haemat... PMid:19454491 PMCid:PMC2704314.
9.
Tsagarakis NJ, Papadhimitriou SI, Pavlidis D, et al. Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia. Int J Lab Hematolo. 2019;41(3):364-72. https://doi.org/10.1111/ijlh.1... PMid:30730614.
10.
Tabernero MD, Bortoluci AM, Alaejos I, et al. Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression. Leukemia. 2001;15(3):406-14. https://doi.org/10.1038/sj.leu... PMid:11237064.
11.
Hawkins MM, Lancashire ER, Winter DL, et al. The British childhood cancer survivor study: Objectives, methods, population structure, response rates and initial descriptive information. Pediatr Blood Cancer. 2008;50(5):1018-25. https://doi.org/10.1002/pbc.21... PMid:17849473.
12.
Blunck CB, Terra-Granado E, Noronha EP, et al. CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemia. Hematol Transfus Cell Ther. 2019;41(3):205-11. https://doi.org/10.1016/j.htct... PMid:31085145 PMCid:PMC6732401.
13.
van der Weyden L, Giotopoulos G, Rust AG, et al. Modeling the evolution of ETV6-RUNX1-induced B cell precursor acute lymphoblastic leukemia in mice. Blood. 2011;118(4):1041-51. https://doi.org/10.1182/blood-... PMid:21628403 PMCid:PMC3622520.
14.
Pais AP, Amare Kadam PS, Raje GC, et al. RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1 negative patients: Its hemato-pathological and prognostic significance in a large cohort (619 Cases) of ALL. Pediatr Hematol Oncol. 2008;25(6):582-97. https://doi.org/10.1080/088800... PMid:18728978.
15.
Kiyokawa N, Iijima K, Tomita O, et al. Significance of CD66c expression in childhood acute lymphoblastic leukemia. Leuk Res. 2014;38(1):42-8. https://doi.org/10.1016/j.leuk... PMid:24231528.
16.
Molina O, Bataller A, Thampi N, et al. Near-haploidy and low-hypodiploidy in B-cell acute lymphoblastic leukemia: When less is too much. Cancers (basel). 2021;14(1):32. https://doi.org/10.3390/cancer... PMid:35008193 PMCid:PMC8750410.
17.
Pierzyna-Świtała M, Sędek Ł, Kulis J, et al. Multicolor flow cytometry immunophenotypingand characterization of aneuploidy in pediatricB-cell precursor acute lymphoblastic leukemia. Cent Eur J Immunol. 2021; 46(3):365-74. https://doi.org/10.5114/ceji.2... PMid:34764809 PMCid:PMC8574114.
Share
RELATED ARTICLE
| eISSN: | 2516-3507 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
